Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA review
Biotech
FDA reveals 2nd round of 'national priority' voucher winners
The program is designed to cut the agency's typical 10- to 12-month review timeline down to just one or two months.
Darren Incorvaia
Nov 6, 2025 3:12pm
FDA debuts priority review voucher with 2-month timeline goal
Jun 17, 2025 11:59am
FDA hopes AI can deliver 'rapid or instant' reviews
Jun 11, 2025 12:45pm
FDA launces generative AI tool Elsa a month ahead of schedule
Jun 3, 2025 10:40am
FDA plans to fully adopt generative AI by end of June
May 8, 2025 1:33pm
FDA delays force Daré to shelve phase 3 plans: WSJ
Apr 17, 2025 3:03pm
